Efficacy and safety of concurrent programmed cell death protein 1 inhibitor and definitive radiotherapy with immunonutrition support in esophageal squamous cell cancer: a phase II multicenter clinical trial. - Yuan, Yupei; Luo, Shihong; Wang, Xiaomin; Zheng, Zhiyong; Qi, Qing; Wang, Yunxiao; Chen, Meiling; Yang, Haihua; Gu, Pingjun; Du, Qin; Wu, Xia; Pan, Wenyan; et al. (Radiation Oncology, 2025)